NEWS ARTICLE

LEO Pharma delivered on strategic ambitions and showed resilience during COVID-19 pandemic in 2020

LEO Pharma net sales recovered from COVID-19 impact during the year, reaching DKK 10.1 billion (-6%).

Ballerup, Denmark, March 23, 2021

Read the full story

ALL NEWS

06-22-2021

LEO Pharma announces European Commission approval of Adtralza® (tralokinumab) as the first and only treatment specifically targeting IL-13 for adults with moderate-to-severe atopic dermatitis
03-22-2021

LEO Pharma delivered on strategic ambitions and showed resilience during COVID-19 pandemic in 2020
12-15-2020

LEO Pharma strengthens global leadership team with appointment of Jörg Möller as Executive Vice President, Global Research and Development
10-27-2020

LEO Pharma launches #everydaypsoriasis campaign to mark World Psoriasis Day
09-22-2020

LEO Pharma strengthens global leadership team with appointment of new Executive Vice President, Global Therapeutic & Value Strategy
08-30-2020

LEO Pharma sells portfolio of four products to Cheplapharm
08-19-2020

LEO Pharma unveils ambitious 2030 strategy positioning itself for long-term growth driven by innovation
08-18-2020

LEO Pharma strengthens global leadership team with appointment of new EVP People & Communications
06-29-2020

LEO Pharma strengthens global leadership team
03-12-2020

Updates regarding COVID-19
11-20-2019

LEO Pharma launches Open Innovation in Ontario to support the innovation ecosystem in the province
11-18-2019

LEO Pharma launches Open Innovation program and partnership with the University of Victoria in Canada
11-13-2019

Birgitta Stymne Göransson elected member of LEO Pharma’s Board of Directors
10-29-2019

LEO Pharma enters into option agreement with Ubiquigent for access to novel compounds
10-23-2019

World Psoriasis Day 2019: LEO Pharma launches new campaign to reduce the stigma surrounding psoriasis
06-30-2019

LEO Pharma completes the acquisition of Bayer’s prescription dermatology business
06-02-2019

LEO Pharma appoints Catherine Mazzacco as new CEO
05-09-2019

LEO Pharma Strengthens US footprint and Global Development Team with appointment of Vice Presidents for Global Regulatory Affairs and Global Project Management
04-10-2019

LEO Pharma and Research Project BIOMAP: Towards Personalised Medicine for Inflammatory Skin Diseases
04-08-2019

LEO Pharma and Elektrofi expand partnership to co-develop new antibodies with the aim of achieving improvements in drug delivery within dermatology
03-18-2019

LEO Pharma A/S and LTS Lohmann Therapie-Systeme AG initiate first-ever clinical trial of microarray patches for psoriasis treatment

LEADERSHIP

Meet our Global Leadership Team

The Global Leadership Team is responsible for overall business growth, strategic direction and daily operations.

MEDIA TOOLKIT

We pursue an open and active dialogue with the media

We believe in making our activities and operations accessible to all relevant media

MEDIA ENQUIRIES

Henrik Kyndlev

Director, Global External Communications

Tel: +45 3140 6180

Get in touch